Dr. Aleksander Vayntraub, MD

  • Ridge, NY
  • Radiation oncologist
NPI1316467582PAC ID2264829969
Medicare services, 2024
8,223
Medicare patients, 2024
706
Part D claims, 2024
309
Publications
5
MIPS score, 2024
100
Practice address
1 Research Rd, Ridge, NY 11961
Practice phone
Call (631) 751-3000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Port Jefferson Station Medical Oncology

Ridge, New York

See all 4 affiliations

Find Dr. Vayntraub's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Aleksander Vayntraub is a radiation oncologist in Ridge, New York

Dr. Vayntraub practices at Port Jefferson Station Medical Oncology in Ridge, New York.

Dr. Vayntraub's NPI, 1316467582, was assigned on June 20, 2017. Dr. Vayntraub graduated from Ohio State University College of Medicine in 2017. Dr. Vayntraub holds New York license 314600.

NPI and contact details
Medicare PAC ID
2264829969
NPI enumeration date
June 20, 2017
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(631) 751-3000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
35
Medical school graduation
2017

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Aleksander Vayntraub practices at Port Jefferson Station Medical Oncology in Ridge, New York

Dr. Vayntraub's primary practice is Port Jefferson Station Medical Oncology, at 1 Research Rd, Ridge, NY 11961 in Suffolk County. The practice phone is (631) 751-3000.

  • Port Jefferson Station Medical Oncology
    1 Research Rd, Ridge, NY 11961 · Suffolk CountyPhone(631) 751-3000

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Aleksander Vayntraub is affiliated with 3 sites of care and 1 medical group

Dr. Vayntraub's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Dr. Vayntraub is also affiliated with Mather Hospital. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Vayntraub to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Vayntraub

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Aleksander Vayntraub's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vayntraub practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Port Jefferson Station Medical OncologyAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Vayntraub practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Aleksander Vayntraub is one of 385 radiation oncologists in New York

Radiation oncology is Dr. Vayntraub's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Vayntraub is licensed in New York.

Specialties and state licenses

  • Radiation oncology, New YorkPrimaryLicense 314600 · taxonomy 2085R0001X

Radiation oncologists near Dr. Vayntraub

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

385radiation oncologists in New York
8radiation oncologists in Ridge

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Aleksander Vayntraub billed Medicare for 8,223 services in 2024

CMS data shows 8,223 Medicare services from Dr. Vayntraub across 33 procedure codes in 2024, for 706 Medicare patients. Medicare paid $2,367,365 for them. Every service was in an office.

Medicare services, 20248,223
Medicare patients706
Paid by Medicare$2.4M
Procedure codes33

Dr. Vayntraub's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 4,1412024: 4,79416%
Other services
2023: 2,4552024: 2,77113%
Office and hospital visits
2023: 4212024: 49518%
Lab and pathology
2023: 712024: 778%
Surgery
2023: 482024: 48No change
Tests and treatments
2023: 492024: 3822%

Dr. Vayntraub compared with the New York median for radiation oncologists, 2024

  • Dr. Vayntraub
  • New York median
Medicare services
8,223vs 1,0547.8 times
Medicare patients
706vs 1604.4 times
Part D claims
163vs 364.5 times

Medians across 368 radiation oncologists in New York with Dmand AI profiles that report each measure.

Dr. Vayntraub's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Vayntraub

Need commercial claims for Dr. Vayntraub?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vayntraub and other radiation oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Aleksander Vayntraub treated 706 Medicare patients in 2024, average age 76

CMS counts 706 Medicare patients who saw Dr. Vayntraub in 2024. The largest group is 75 to 84, with 305 patients. 75% of them have cancer, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vayntraub's median patient age at 72, with 50% women.

Medicare patients, 2024706
Average age76
Average risk score2.04
Also on Medicaid11%

Dr. Vayntraub's Medicare patients by age, 2024

Dr. Vayntraub's Medicare patients by sex, 2024

  • Women39356%
  • Men31344%

Chronic conditions among Dr. Vayntraub's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Arthritis48%
  5. Ischemic heart disease44%
  6. Diabetes37%
  7. Chronic kidney disease31%
  8. Anxiety30%

Share of Medicare patients with each condition. A patient can have several.

Dr. Vayntraub's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women50%
  • Men48%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Aleksander Vayntraub wrote 309 Medicare Part D claims in 2024

In 2024, Dr. Vayntraub wrote 309 Medicare Part D claims for 126 patients. 92% of them were for generic drugs. CMS names the drug for 163 of them, across 8 drugs with 11 or more claims each, at $1,816 in total drug cost. In 2023, CMS named 169 claims across 9 drugs.

Part D claims, 2024309
Drugs named by CMS8
Total drug cost$1,816
Part D patients126

Dr. Vayntraub's Part D claims by kind of drug, 2024

  • Generic284 claims92%
  • Brand-name25 claims8%

Dr. Vayntraub's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Vayntraub's Part D claims, 2024

  • Opioids8%24 of 309 claims
  • Antibiotics4%12 of 309 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1692024: 1634%

Drugs named by CMS: 8 in 2024, 9 in 2023.

See all prescribing by Dr. Vayntraub

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Aleksander Vayntraub scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Vayntraub for performance year 2024, reported as part of a group. Dr. Vayntraub accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vayntraub as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Vayntraub's MIPS scores, performance year 2024

  • 100of 100Final score
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Vayntraub by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Aleksander Vayntraub has 5 publications on record

Dmand AI links 5 papers to Dr. Vayntraub, published from 2020 to 2023. The most frequent topics are Radiotherapy Dosage, Breast Neoplasms and Coronary Vessels. Dr. Vayntraub's most frequent co-authors are Muayad Almahariq, MD, PhD, Peter Chen, MD and Joshua T. Dilworth.

Papers5
Years published2020 to 2023

Dr. Vayntraub's papers by year, 2020 to 2023

Topics Dr. Vayntraub writes about most

  • Radiotherapy Dosage
  • Breast Neoplasms
  • Coronary Vessels
  • Heart
  • Radiotherapy Planning, Computer-Assisted
  • Unilateral Breast Neoplasms

Dr. Vayntraub's most frequent co-authors

Recent publications by Dr. Vayntraub

See all 5 publications and co-authors

See who Dr. Vayntraub researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Vayntraub works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Aleksander Vayntraub received $1,209 in industry payments from 2017 to 2025

CMS Open Payments shows 14 general payments to Dr. Vayntraub from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $739.

General payments to Dr. Vayntraub by program year, 2017 to 2025

Companies that paid Dr. Vayntraub the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Vayntraub

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Aleksander Vayntraub graduated from Ohio State University College of Medicine

Dr. Vayntraub graduated from Ohio State University College of Medicine in 2017.

  1. Medical schoolOhio State University College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Aleksander Vayntraub's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Aleksander Vayntraub

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Aleksander Vayntraub's NPI number?

Dr. Aleksander Vayntraub's NPI number is 1316467582. It was assigned on June 20, 2017, and it is active in the NPI Registry.

What kind of doctor is Dr. Aleksander Vayntraub?

Dr. Aleksander Vayntraub is a radiation oncologist in Ridge, New York. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Aleksander Vayntraub practice?

Dr. Vayntraub practices at 1 Research Rd, Ridge, NY 11961. Dr. Vayntraub's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Dmand AI also links Dr. Vayntraub to 1 group practice or clinic.

What is Dr. Aleksander Vayntraub's office phone number?

The practice phone on file for Dr. Vayntraub is (631) 751-3000.

What is Dr. Aleksander Vayntraub's medical license number?

Dr. Vayntraub holds New York license 314600.

Which hospitals is Dr. Aleksander Vayntraub affiliated with?

Dr. Vayntraub is affiliated with Mather Hospital.

What medical group is Dr. Aleksander Vayntraub part of?

Dr. Vayntraub is linked to New York Cancer & Blood Specialists.

Does Dr. Aleksander Vayntraub accept Medicare?

Yes. CMS data shows Dr. Vayntraub billed Medicare for 8,223 services in 2024, and Dr. Vayntraub accepts Medicare assignment.

Does Dr. Aleksander Vayntraub offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Vayntraub as offering telehealth services.

What is Dr. Aleksander Vayntraub's MIPS score?

Dr. Vayntraub's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Aleksander Vayntraub see?

CMS counts 706 Medicare patients who saw Dr. Vayntraub in 2024, with an average age of 76.

What services does Dr. Aleksander Vayntraub bill to Medicare?

In 2024, Dr. Vayntraub's most billed Medicare services were medicare service (G6015), radiation oncology (77014) and radiation oncology (77300).

Where did Dr. Aleksander Vayntraub go to medical school?

Dr. Vayntraub graduated from Ohio State University College of Medicine in 2017.

What drugs does Dr. Aleksander Vayntraub prescribe most?

In 2024 Medicare Part D data, Dr. Vayntraub's most prescribed drugs by claims were Tamsulosin HCl, Mometasone Furoate and Omeprazole.

Has Dr. Aleksander Vayntraub received payments from drug or device companies?

CMS Open Payments shows $1,209 in general payments to Dr. Vayntraub from 7 companies from 2017 to 2025. The largest total came from Novocure Inc.

How long has Dr. Aleksander Vayntraub been practicing?

Dr. Vayntraub graduated from medical school in 2017, 9 years ago.

Does Dr. Aleksander Vayntraub do research?

Dmand AI links 5 publications to Dr. Vayntraub, published from 2020 to 2023.

Who does Dr. Aleksander Vayntraub publish with?

Dr. Vayntraub's most frequent co-authors are Muayad Almahariq, MD, PhD (2 shared papers), Peter Chen, MD (2 shared papers) and Joshua T. Dilworth (2 shared papers).

Selling to radiation oncology practices?

See radiation oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)